BioAsia and BioRx will conduct a workshop on Private Equity (PE) and and Venture Capital (VC) in Lifesciences sector, a perspective changing interactive event. The workshop will be held on the sidelines of BioAsia-2013. It will take place at HICC, Hyderabad on January 28, 2013.
The target audience will be CEOs, CFOs, corporate treasurers and board members of life sciences companies, private bankers and wealth managers, investment bankers and security analysts, corporate lawyers, risk managers and structured financial professionals.
The workshop will provide an update on Indian VC and PE market; Due diligence-key imperatives, The Art of valuation: How does VC/PE value a company; Legal aspect of PE/VC and exit strategies.
BioAsia 2013 to be held at Genome Valley, Hyderabad from January 28 to 30, 2013, will seek to enhance, enrich and encourage newer innovations, path-breaking discoveries and effective solutions in the industry by offering a vibrant global platform for convergence of the key stakeholders—biotech and biopharma companies, research institutions, investors, service providers, policy makers, regulators and analysts.
With an objective of optimising the immense business potential of biotech, BioAsia enables an effective environment for fostering collaborations, joint ventures, M&As that has increasingly become an integral part of industry growth agenda.
EP News Bureau – Mumbai
- Advertisement -
